Baird Medical Investment Holdings (BDMD) Preferred Shares (2024 - 2025)

Baird Medical Investment Holdings' (BDMD) quarterly Preferred Shares came in at $29.0 in Q4 2025, little changed year-on-year from $29.0 in Q4 2024, and little changed on a QoQ basis from $29.0 in Q2 2025.

Baird Medical Investment Holdings (BDMD) Preferred Shares (2024 - 2025) Analysis & Trends

Baird Medical Investment Holdings (BDMD) has 2 years of Preferred Shares data on file, last reported at $29.0 in Q4 2025.

  • On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $29.0 in Q4 2025; TTM through Dec 2025 was $29.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $29.0, changed 0.0% from the prior year.
  • Preferred Shares for Q4 2025 stood at $29.0, roughly flat from $29.0 in the prior quarter.
  • Over the last five years, Preferred Shares for BDMD reached as high as $29.0 in Q4 2024 and fell as low as $29.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Baird Medical Investment Holdings 30.57 Mn 30.04 Mn - 29.00

Historic Data

Download Data
DateValue
Dec 31, 2025 29.00
Jun 30, 2025 29.00
Dec 31, 2024 29.00